PTPN2 and breast carcinoma: TCPTP protein levels are reduced in a subset of estrogen receptor, progesterone receptor and HER2 triple-negative human breast cancers, and TCPTP deficient breast cancer cell lines exhibit elevated SFK signaling [43].